Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Drug Approval | 4 | 2018 | 1325 | 1.11 | Why? |
| Pharmacists | 3 | 2020 | 1246 | 0.79 | Why? |
| Legislation, Hospital | 1 | 2018 | 24 | 0.75 | Why? |
| Clonidine | 1 | 2018 | 31 | 0.73 | Why? |
| Adrenergic alpha-2 Receptor Agonists | 1 | 2018 | 47 | 0.72 | Why? |
| Equipment and Supplies, Hospital | 1 | 2021 | 272 | 0.72 | Why? |
| Legislation, Medical | 1 | 2018 | 66 | 0.68 | Why? |
| Substance Withdrawal Syndrome | 1 | 2018 | 137 | 0.63 | Why? |
| Hospitals, Rural | 1 | 2018 | 185 | 0.61 | Why? |
| United States Food and Drug Administration | 6 | 2018 | 1276 | 0.61 | Why? |
| Pharmaceutical Services | 1 | 2020 | 347 | 0.56 | Why? |
| Drug Costs | 2 | 2018 | 313 | 0.55 | Why? |
| Prospective Payment System | 1 | 2014 | 28 | 0.54 | Why? |
| Narcotic Antagonists | 1 | 2018 | 317 | 0.53 | Why? |
| Isotretinoin | 1 | 2012 | 58 | 0.46 | Why? |
| Smallpox Vaccine | 1 | 2011 | 46 | 0.45 | Why? |
| Migraine Disorders | 1 | 2018 | 530 | 0.44 | Why? |
| Medical Informatics | 1 | 2018 | 648 | 0.42 | Why? |
| Wet Macular Degeneration | 1 | 2012 | 102 | 0.42 | Why? |
| Smallpox | 1 | 2011 | 96 | 0.42 | Why? |
| Pharmacy Service, Hospital | 4 | 2020 | 645 | 0.39 | Why? |
| Vaccinia virus | 1 | 2011 | 346 | 0.38 | Why? |
| Blood Substitutes | 1 | 2008 | 6 | 0.38 | Why? |
| Product Surveillance, Postmarketing | 1 | 2010 | 189 | 0.35 | Why? |
| Immunization Programs | 1 | 2021 | 2006 | 0.35 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2012 | 604 | 0.34 | Why? |
| Health Resources | 1 | 2021 | 2592 | 0.33 | Why? |
| Prescription Drugs | 1 | 2010 | 243 | 0.32 | Why? |
| Hospitals | 3 | 2021 | 11793 | 0.32 | Why? |
| Recombinant Fusion Proteins | 1 | 2012 | 919 | 0.32 | Why? |
| Technology, Pharmaceutical | 1 | 2006 | 82 | 0.31 | Why? |
| Opioid-Related Disorders | 1 | 2018 | 1185 | 0.30 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2013 | 877 | 0.30 | Why? |
| Dermatologic Agents | 1 | 2012 | 489 | 0.30 | Why? |
| Electronic Health Records | 1 | 2018 | 3492 | 0.28 | Why? |
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2003 | 2 | 0.27 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2018 | 9335 | 0.27 | Why? |
| Medication Systems | 1 | 2003 | 16 | 0.27 | Why? |
| Hemoglobins | 1 | 2008 | 958 | 0.23 | Why? |
| Drug Therapy, Combination | 1 | 2015 | 7268 | 0.22 | Why? |
| Health Facility Planning | 1 | 2021 | 32 | 0.22 | Why? |
| Alaska | 1 | 2021 | 100 | 0.22 | Why? |
| Diuretics | 1 | 2003 | 326 | 0.22 | Why? |
| Tissue Plasminogen Activator | 1 | 2007 | 778 | 0.21 | Why? |
| Chronic Disease | 1 | 2015 | 5139 | 0.21 | Why? |
| Nanotechnology | 1 | 2006 | 821 | 0.20 | Why? |
| Arizona | 1 | 2021 | 416 | 0.20 | Why? |
| Government Regulation | 1 | 2006 | 842 | 0.19 | Why? |
| Calcitonin Gene-Related Peptide | 1 | 2018 | 52 | 0.18 | Why? |
| Blood Transfusion | 1 | 2008 | 1399 | 0.18 | Why? |
| Automation | 1 | 2021 | 429 | 0.18 | Why? |
| United States | 9 | 2018 | 46150 | 0.17 | Why? |
| Antineoplastic Agents | 1 | 2013 | 3550 | 0.17 | Why? |
| Georgia | 1 | 2021 | 955 | 0.17 | Why? |
| Influenza Vaccines | 1 | 2013 | 2941 | 0.16 | Why? |
| Economics, Hospital | 1 | 2018 | 97 | 0.16 | Why? |
| Fibrinolytic Agents | 1 | 2007 | 1702 | 0.15 | Why? |
| Legislation, Pharmacy | 1 | 2014 | 19 | 0.14 | Why? |
| Insurance, Pharmaceutical Services | 1 | 2014 | 19 | 0.14 | Why? |
| Valsartan | 1 | 2015 | 206 | 0.13 | Why? |
| Biphenyl Compounds | 1 | 2015 | 249 | 0.13 | Why? |
| Aminobutyrates | 1 | 2015 | 142 | 0.13 | Why? |
| Heart Failure | 1 | 2015 | 6638 | 0.13 | Why? |
| Drug Labeling | 1 | 2013 | 65 | 0.13 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.13 | Why? |
| Health Planning | 1 | 2021 | 607 | 0.13 | Why? |
| Patient Care Team | 1 | 2007 | 3556 | 0.12 | Why? |
| Tetrazoles | 1 | 2015 | 262 | 0.12 | Why? |
| Receptors, Vascular Endothelial Growth Factor | 1 | 2012 | 61 | 0.12 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.10 | Why? |
| Risk Assessment | 2 | 2012 | 25439 | 0.10 | Why? |
| Influenza, Human | 1 | 2013 | 10779 | 0.09 | Why? |
| Analgesics, Opioid | 1 | 2018 | 1070 | 0.09 | Why? |
| Humans | 18 | 2021 | 930598 | 0.09 | Why? |
| Forecasting | 1 | 2021 | 4492 | 0.08 | Why? |
| Drug Combinations | 1 | 2015 | 3852 | 0.07 | Why? |
| Chlorthalidone | 1 | 2003 | 7 | 0.07 | Why? |
| Stroke | 1 | 2007 | 8839 | 0.07 | Why? |
| Lisinopril | 1 | 2003 | 25 | 0.07 | Why? |
| Amlodipine | 1 | 2003 | 45 | 0.06 | Why? |
| Terminology as Topic | 1 | 2006 | 546 | 0.05 | Why? |
| Hypertension | 1 | 2003 | 8895 | 0.05 | Why? |
| Patient Education as Topic | 1 | 2010 | 1476 | 0.05 | Why? |
| Drug Design | 1 | 2011 | 2627 | 0.05 | Why? |
| Nanostructures | 1 | 2006 | 700 | 0.05 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2015 | 3892 | 0.05 | Why? |
| Quality Assurance, Health Care | 1 | 2003 | 596 | 0.04 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2006 | 1261 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Ambulatory Care | 1 | 2014 | 4947 | 0.04 | Why? |
| Health Facilities | 1 | 2003 | 1230 | 0.04 | Why? |
| Safety Management | 1 | 2003 | 1093 | 0.04 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.03 | Why? |
| Pharmaceutical Preparations | 1 | 2006 | 1897 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
| Antihypertensive Agents | 1 | 2003 | 1962 | 0.03 | Why? |
| Myocardial Infarction | 1 | 2003 | 3361 | 0.02 | Why? |
| Clinical Trials as Topic | 1 | 2003 | 7330 | 0.02 | Why? |
| Animals | 1 | 2011 | 78931 | 0.01 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.01 | Why? |
Traynor's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(101)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_